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Between September and October of 2004, more than 1230 cases of gastroenteritis
due to pandemic O3:K6 strains of Vibrio parahaemolyticus (V. parahaemolyticus) were
reported in the relatively small geographical area of Southern Sinaloa, a state located in
Northwest Mexico. Since then, V. parahaemolyticus-associated gastroenteritis cases
have gradually increased in prevalence spreading from south to north. The present
study conducted an epidemiological surveillance of V. parahaemolyticus strains in both
environmental and clinical samples along the Pacific coast of Sinaloa from 2011 to
2013. The genetic relatedness, serotype dominance and antibiotic resistance of isolates
were investigated. A total of 46 strains were isolated from environmental samples
(e.g., sediment, seawater and shrimp), whereas 249 strains were obtained from stools
of patients with gastroenteritis. Nine different O serogroups and 16 serovars were
identified. Serovars O3:K6 and O6:K46 were identified in both environmental and clinical
strains. Whereas most environmental isolates carried the tdh gene (71.74%, 33/46),
only three (6.52%) belonged to pandemic clones (O3:K6, O3:KUT and OUT:KUT).
In contrast, 81.1% (202/249) of clinical isolates belonged to pandemic serotypes,
with O3:K6 (tdh, toxRS/new, and/or orf8) representing the predominant serovar (97%,
196/202). This prevalence of pathogenic (tdh and/or trh positive) and O3:K6 pandemic
V. parahaemolyticus isolates in this study were similar to those found from 2004 to
2010. As investigated by REP-PCR, genetic lineages of selected O3:K6 strains isolated
in this study and some isolated earlier were nearly identical. Antimicrobial susceptibility
testing showed that most strains (93.8%) were resistant to ampicillin but sensitive to
chloramphenicol (98.8%). Multidrug resistance significantly increased from 8.6% (2004–
2010) to 22.93% (2011–2013; p < 0.05). Our data indicate that pandemic O3:K6 clone
has endemically established in the Pacific Coast of Mexico.
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Introduction
Vibrio parahaemolyticus is a Gram stain-negative bacterium
autochthonous of marine and estuarine environments worldwide
(Kaneko and Colwell, 1973, 1978; Joseph et al., 1982). While
the majority of environmental strains are innocuous members of
the marine microbiota, small subpopulations are opportunistic
pathogens of humans (Johnson et al., 2008). Potentially virulent
strains are commonly diﬀerentiated from likely avirulent strains
by the presence of the thermostable direct (tdh) and/or tdh-
related (trh) hemolysin genes (Shirai et al., 1990; Bej et al., 1999).
Acute gastroenteritis is the most commonmanifestation of illness
and often associated with the consumption of raw or under-
cooked oysters, which can bioaccumulate the bacterium through
ﬁlter-feeding (Daniels et al., 2000; Su and Liu, 2007; Iwamoto
et al., 2010).
Previously, V. parahaemolyticus infections have been typically
sporadic cases attributed to multiple serotypes, with at least 13 O
serogroups and 71 K serotypes detected (Ishibashi et al., 2000).
There was not a clear association between V. parahaemolyticus-
mediated infection and serovars until 1996. Serogroup O3:K6 was
ﬁrst isolated in 1996 from diarrhea patients in Kolkata, India
(Okuda et al., 1997) and subsequently worldwide. Since then an
increasing incidence of gastroenteritis caused by the serogroup
O3:K6 has been reported in many countries, including Africa
(Ansaruzzaman et al., 2005), Europe (Martinez-Urtaza et al.,
2004, 2005), and Latin America (Gonzalez-Escalona et al., 2005).
Serotype O3:K6 strain was then identiﬁed as a dominant pan-
demic clone from clinical cases of V. parahaemolyticus-induced
diarrhea reported globally (Okuda et al., 1997; Chowdhury et al.,
2000).
Up to now, a wide variety of O3:K6 clonal derivatives, includ-
ing O4:K68, O1:K25, O1:K26, andO1:KUT, have been recognized
as the predominant group responsible for most outbreaks since
1996 (Okuda et al., 1997; Matsumoto et al., 2000; Okura et al.,
2004;Ansaruzzaman et al., 2005; Hayat Mahmud et al., 2006).
Pandemic strains typically belong to serotype O3:K6 and encodes
a unique orf8 gene (Nasu et al., 2000). It has been hypothesized
that orf8 encodes for an adherence protein that increases the
ability of V. parahaemolyticus to adhere to host intestinal cells
or the surfaces of marine plankton (Nasu et al., 2000; Yeung
et al., 2002). Several studies reported that the toxRS operon of
pandemic strains contains a unique sequence, thereby referred
as toxRS/new, encoding transmembrane proteins involved in
the regulation of virulence associated genes (Chowdhury et al.,
2000; Okura et al., 2003, 2005). In general, an isolate possessing
both tdh and toxRS/new can be considered as a pandemic strain
(Okura et al., 2003). Another known virulence gene, trh, is not
speciﬁc to pandemic strains and it is rarely present in environ-
mental strains compared to clinical ones (DePaola et al., 2000;
Parvathi et al., 2006).
In Mexico, the ﬁrst outbreak of gastroenteritis caused by the
pandemic strain of V. parahaemolyticus O3:K6 was reported in
2004 (Cabanillas-Beltran et al., 2006). More than 1230 cases
of infection with V. parahaemolyticus were associated to con-
sumption of contaminated seafood in a relatively small geo-
graphic area in southern Sinaloa (Cabanillas-Beltran et al., 2006).
The incidence of V. parahaemolyticus infections in Mexico was
unknown until 2004 when the O3:K6 pandemic strain with the
tdh virulence gene was detected in this region. In subsequent
years, recurrent sporadic cases has been detected in both South
and North areas with the pandemic strain O3:K6 causing >79%
of reported cases between 2004 and 2010 (Velazquez-Roman
et al., 2012).
In an eﬀort to understand the prevalence and dissemination
of V. parahaemolyticus strains (toxigenic and pandemic O3:K6)
we have characterized since 2004 strains of V. parahaemolyti-
cus isolated from both clinical cases and environmental sam-
ples obtained from South and North areas of the Sinaloa state
(Velazquez-Roman et al., 2012). The present report describes
a more extensive investigation that evaluated the prevalence of
V. parahaemolyticus strains in clinical and environmental sam-
ples collected from 2011 through 2013 from along all Sinaloa
state. Our studies characterized the isolates by serotyping, investi-
gated their antimicrobial susceptibility or non-susceptibility and
assessed the presence of toxigenic and pandemic genetic markers.
We also investigated the genetic relationships of strains isolated
between 2004 and 2010 to those investigated in this study and
isolated in 2011–2013. Our results indicate the persistence in the
environment and clinical cases of the O3:K6 pandemic strain in
Northwest Mexico from 2004 to 2013 To our knowledge, this
is the ﬁrst report describing that the pandemic O3:K6 clone has
endemically established in the Paciﬁc Coast of Mexico and causes
most V. parahaemolyticus attributable diarrhea cases.
Materials and Methods
Area of Study, Collection of Environmental
Samples, and Stool Samples
This study was performed in the state of Sinaloa, which is located
in Northwest Mexico. Sinaloa has over 650 km of coastline,
with most of it (∼75%) facing the Sea of Cortez and the rest
(∼25%) bordering the Paciﬁc Ocean. Sample collection was per-
formed in eleven sites from the southern to the northern region
in Sinaloa, during the years of 2011, 2012, and 2013. Regions
sampled include were leading shrimp producers in Sinaloa are
located; clinical cases were also detected near these regions. A
total of 1,895 environmental samples (shrimp N = 204, sedi-
ment N = 9, and seawater N = 1,682) were collected (Figure 1).
Stool specimens or rectal swabs (N = 10,521) were collected
in Cary-Blair transport medium from persons with clinical gas-
troenteritis who had eaten seafood and requested attention in
public-sector health care agencies during the period 2011–2013
(Figure 1). Written informed consent was obtained from patients
or their families. Procedures for collection of stool samples were
approved by the ethics committee of the Faculty ofMedicine-UAS
and the Sinaloa State Public Health Laboratory.
Bacteriological Analyses
Samples were processed following procedures found in the
Bacteriological Analytical Manual of the Food and Drug
Administration (Kaysner and De Paola, 2004) and as described
by Canizalez-Roman et al. (2011). Brieﬂy, 50 g of shrimp, or
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FIGURE 1 | Area of study and locations of the sampling sites in the
Pacific Northwest coast of Mexico. Clinical cases (stools specimens or
rectal swabs; n = 10,521 of which 249 were positive isolates for Vibrio
parahaemolyticus) and environmental samples (seawater, sediment, and shrimp;
n = 1,895 of which 46 were positive isolates for V. parahaemolyticus) collected
from 2011 through 2013 in the coastal regions of northern to southern Sinaloa.
sediment samples, or 50 mL of seawater, were homogenized
with 450 mL of sterile alkaline peptone water (APW; pH 8.6)
in a Stomacher 400 circulator. The APW homogenate was incu-
bated at 37◦C for 6–8 h. Stool samples, or rectal swabs, were
placed in Cary-Blair transport medium and transported at room
temperature (RT) to the laboratory within 2 h and immedi-
ately processed. These specimens were also enriched in APW
(pH 8.6) for 6–8 h at 37◦C. After incubation, the enrichment
broths were streaked onto thiosulfate-citrate-bile salts-sucrose
(TCBS) agar plates and/or CHROMagar Vibrio (CV) medium
(CHROMagar, Paris, France) and incubated at 37◦C for 18–
24 h. At least three typical colonies of V. parahaemolyticus were
isolated from each plate and subjected to identiﬁcation by bio-
chemical test and polymerase chain reaction (PCR) as mentioned
below. After identiﬁcation of V. parahaemolyticus a single colony
from each sample was used to continue the analysis (serotyping
and virulence genes).
Extraction and Purification of Chromosomal
DNA
Chromosomal DNA was extracted using the Wizard genomic
DNA puriﬁcation kit (Promega Corp.) according to the manu-
facturer’s instructions. Brieﬂy, strains were inoculated in LB broth
containing 3% NaCl an incubated overnight at 37◦C. This culture
(3 mL) was pelleted by centrifugation at 16,000 × g for 5 min.
Cells were lysed at 80◦C in nucleic lysis solution. RNase solution
was added to the cell lysate, followed by incubation at 37◦C for 1 h
and cooling at RT. Protein precipitation solution was added to the
RNase-treated cell lysate and vortexed vigorously. DNA was pre-
cipitated by adding 0.6 volumes of isopropanol at RT and then
washed with 70% ethanol; air dried, and solubilized using DNA
rehydration solution. Our DNA preparations were stored at −20
or −80◦C until use.
PCR Assays
Polymerase chain reaction ampliﬁcation was performed in 25 µL
reactions consisting of 1X GoTaq green master mix (Promega),
primers targeting either the tl gene (Bej et al., 1999), pR72H plas-
mid (Lee et al., 1995; Robert-Pillot et al., 2002), tdh or trh genes
(Bej et al., 1999), and 0.5 µL of puriﬁed genomic DNA template,
with the remaining volume consisting of molecular biology grade
water. PCR was routinely carried out in a Thermal Cycler C1000
(Bio-Rad Laboratories, Hercules, CA, USA) under the following
cycling conditions: an initial period of DNA denaturation at 94◦C
for 3 min, followed by 35 cycles of 1 min at 94◦C, 1 min at 58◦C,
and 1 min at 72◦C, and a ﬁnal extension of 5 min at 72◦C. PCR
assays to amplify the toxRS/new and orf8 genes (pandemic mark-
ers) were performed using speciﬁc primers previously reported
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to detect toxRS/new (Matsumoto et al., 2000) sequence unique to
the pandemic clone of V. parahaemolyticus and the orf8 (Myers
et al., 2003) sequence of phage f237, respectively. PCR conditions
for these assays were the following: for the toxRS/new gene, ini-
tial denaturation at 94◦C for 3 min, followed by 25 cycles of 30 s
at 94◦C, 30 s at 45◦C, and 1 min at 72◦C, with a ﬁnal extension
of 5 min at 72◦C, and for the orf8 gene, denaturation at 94◦C for
3 min, followed by 30 cycles of 30 s at 94◦C, 30 s at 55◦C, and
30 s at 72◦C, with a ﬁnal extension of 5 min at 72◦C (Matsumoto
et al., 2000; Myers et al., 2003). Ten microliter aliquots of each
ampliﬁcation product were separated by electrophoresis in 2%
agarose gels. Ethidium bromide staining (0.5 mg/mL) allowed for
the visualization of DNA fragments with a digital imaging system
(Gel Doc EZ imager, Bio-Rad, Hercules, CA, USA). The sizes of
the PCR fragments were compared against a 50-bp DNA ladder
(Promega DNA step ladder).
Serotyping
Serotyping of V. parahaemolyticus isolates was done by using
a commercially available V. parahaemolyticus antiserum test kit
(Denka Seiken, Tokyo, Japan) with O1–O11 antisera and 71
K antisera according to the manufacturer’s instructions. Brieﬂy,
strains were grown overnight at 37◦C on LB agar containing 3%
NaCl. A pool of colonies was suspended in 1 mL of saline and
then split in two 500 µL aliquots. For serotyping, an aliquot was
heated up to 121◦C for 1 h for O serotyping; if the serotype could
not be obtained, the bacterial lysate was heated for an additional
hour and then used for O serotyping. The second aliquot was used
for serotyping based on the K antigen.
REP-PCR
More than 50% (n = 150) of strains isolated between 2004–2010
and 2011–2013 were selected for repetitive extragenic palin-
dromic PCR (REP-PCR) analysis. Of these only nine strains
are shown in the results section. Strains from the 2004 to
2010 period were obtained from a previous study (Velazquez-
Roman et al., 2012) and from the MEMC (Medical and
Enviromental Microorganism Collection, School of Medicine,
Autonomous University of Sinaloa, Culiacan, Sinaloa, México).
Seven strains belonged to pandemic O3:K6 strains, one strain
sharing serogroup and pandemic characteristics O3:KUT iso-
lated from shrimp sample, and a clinical isolate belonging to
serotype O1:K20. Reactions were performed with primers REP-
1D, 5-NNN RCG YCG NCA TCM GGC-3, and REP-2D, 5-RCG
YCT TAT CMGGCCTAC-3, where M is A or C, R is A or G, Y is
C or T, and N is any nucleotide (Wong and Lin, 2001; Maluping
et al., 2005). PCR was routinely carried out in a Thermal Cycler
C1000 (Bio-Rad Laboratories, Hercules, CA, USA) under the fol-
lowing cycling conditions: an initial period of DNA denaturation
at 95◦C for 7min, followed by 35 cycles of 0.30 min at 94◦C, 1min
at 45◦C, and 8 min at 72◦C, and a ﬁnal extension of 10 min at
72◦C (Wong and Lin, 2001; Maluping et al., 2005). PCR products
were resolved by gel electrophoresis (1.5% agarose) buﬀered in
Tris acetate EDTA (TAE) at 80 V for 2 h, stained with ethidium
bromide (0.5 mg/mL) allowed for the visualization of DNA frag-
ments with a digital imaging system (Bio-Rad Gel Doc EZ Imager,
Wayne, PA, USA).
FIGURE 2 | Prevalence of pandemic Vibrio parahaemolyticus O3:K6
and pathogenic strains isolated from environmental and clinical
samples that were collected in periods 2004–2010 or 2011–2013.
Antibiotic Susceptibility Testing
To evaluate antimicrobial-susceptibility of V. parahaemolyticus
strains, 65 clinical and 87 enviromental isolates from 2004 to
2010 (from MEMC, a previous study (Velazquez-Roman et al.,
2012), and 77 clinical and 32 enviromental isolates from 2011
to 2013, were tested by a standard disk diﬀusion method on
Mueller-Hinton II agar (CLSI, 2011). The antibiotic sensi-disk
(BD BBL, Sensi-Disc, Becton, Dickinson and Company, USA)
used were the following: ampicillin (10 µg), tetracycline (30 µg),
trimethoprim–sulfamethoxazole (1.25 µg/23.75 µg), chloram-
phenicol (30 µg), nalidixic acid (30 µg), ciproﬂoxacin (5 µg),
ceftazidime (30 µg), gentamicin (10 µg), and cefotaxime (30 µg).
In the absence of Clinical and Laboratory Standards Institute
(CLSI) deﬁnitive standards for interpreting V. parahaemolyti-
cus susceptibility to antibiotics, zone diameters were determined
and recorded as sensitive, intermediate, or resistant according
to established standards for V. cholerae and Enterobacteriaceae.
The following V. parahaemolyticus strains were used as a control
organism: ATCC17802, (tdh−) andmultidrug resistant strain 727
(Leon-Sicairos et al., 2009).
Statistical Analysis
All statistical analysis was performed using SPSS v.20.0 (IBM
Corp., Armonk, NY, USA).We carried out Chi-square to evaluate
signiﬁcance.
Results
Isolation of V. parahaemolyticus from
Environmental and Stool Samples
From 2011 to 2013, a total of 1,895 environmental samples were
analyzed for the presence of V. parahaemolyticus strains; these
samples included 204 shrimp, 1682 seawater and nine sediment
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samples (Figure 1). Overall,V. parahaemolyticus strains were iso-
lated from 2.4% (N = 46) of samples. Of these 46 strains, 38
(82.6%) were obtained from shrimp samples, 5 (10.9%) from sed-
iment, and 3 (6.5%) from seawater. In clinical samples taken
during the same period,V. parahaemolyticus strains were isolated
in 249 (2.4%) out of 10,521 stool specimens or rectal swabs col-
lected from persons with gastroenteritis who had eaten seafood.
The presence ofV. parahaemolyticus in both, environmental sam-
ples and in cases of diarrhea by this bacterium were detected from
southern to northern Sinaloa state (Figure 1).
Virulence Genes, Serotypes and Pandemic
Characteristics of V. parahaemolyticus
Isolates
Based on the presence or absence of virulence genes, we classi-
ﬁed the isolates into three groups: pandemic (tdh+ , toxRS/new+
and/or orf8+), pathogenic (tdh+ and/or trh+), and non-
pathogenic strains (tdh− and trh−). Among environmental V.
parahaemolyticus strains, three strains (6.5%) were identiﬁed as
pandemic isolates. One of these strains belonged to serotype
O3:K6 and carried the tdh, toxRS/new, and orf8 genes (isolated
from shrimp), whereas two pandemic O3:KUT strains carried
the tdh, toxRS/new and/or orf8 genes (isolated from sediment
and shrimp). A total of 65.2% (30/46) of environmental isolates
carried the virulence tdh gene and therefore are considered as
pathogenic strains. We did not detect isolates encoding the trh
gene (Table 1). Approximately 28% (13/46) of environmental
isolates were non-pathogenic. The most prevalent serovars were
O3:KUT (23.9%, 11/46) and O5:K30 (10.8%, 5/46). Non-typeable
strains represented the 39.13% (18/46; Table 1). Regarding V.
parahaemolyticus strains isolated from diarrhea cases, 81.1%
(202/249) of these isolates were identiﬁed as pandemic serotypes
(Table 1). Of these, 97% (196/202) belonged to serovar O3:K6,
carrying the tdh, toxRS/new and/or orf8 genes. One isolate
belonged to serovar O3:K29 (tdh+ and toxRS/new+), and one
isolate belonged to serotype OUT:KUT (tdh+, toxRS/new+, and
orf8+). A total of 16.1% (40/249) of these clinical isolates were
pathogenic strains (tdh+ and/or trh+) including several serotypes
(e.g., O1:KUT, O4:K12, O4:K29, O4:K55, O6:K18, O10:KUT,
OUT:KUT, OUT:K53, O1:K56, O3:KUT, O4:KUT, O8:K21). Only
few clinical isolates, 2.8% (7/249), were classiﬁed within the
non-pathogenic group. Unlike serovars detected in environ-
mental isolates, pandemic serotype O3:K6 (80.3%, 200/249) was
the most prevalent among those isolated from clinical samples
(Table 1). Serotypes O1:KUT, O2:KUT, O3:KUT, O3:K6, O6:K46,
and OUT:KUT were isolated from both environmental samples
and stool samples.
Prevalence of O3:K6 Pandemic Clone and
Pathogenic Strains between 2004–2010 and
2011–2013
The pandemic clone O3:K6 serotype was the most prevalent
strain isolated from gastroenteritis cases in both periods 2004–
2010 (81.8%) and 2011–2013 (80.3%). Among environmental
strains the prevalence of serotype O3:K6 was also similar, 2.7
or 2.1%, for those isolated in 2004–2010, or 2011–2013, respec-
tively (Figure 2). The percentage of clinical pathogenic strains
isolated during the period 2011–2013 (16.1%) was slightly higher
than that obtained during the period 2004–2010 (11%) but sta-
tistical analysis revealed no signiﬁcant diﬀerence (p > 0.05).
In the case of environmental pathogenic strains the prevalence
increased from 52% in 2004–2010 to 65.3% in our period of
analysis 2011–2013 (Figure 2). Similarly, no statistically signif-
icant diﬀerence was detected (p > 0.05). This indicates that
the incidence of V. parahaemolyticus infection by the pandemic
strains (O3:K6) in this region of Mexico had remained constant
since 2004. It is noteworthy that between 2004 and 2013, O3:K6
strains were isolated from clinical samples in high proportions
(80.3–81.8%) whereas pathogenic strains were detected in low
proportions (11–16.1%). Conversely, in environmental samples
the pandemic clone O3:K6 was detected in low proportions (2.1–
2.7%) and pathogenic strains were detected in high proportions
(52–65.3%).
REP-PCR Typing of Clinical and
Environmental V. parahaemolyticus Strains
To investigate whether infections due to pandemic isolates were
caused by genetic related clones throughout the years, DNA
ﬁngerprints of 150 strains obtained during 2004–2013 were
examined using REP-PCR, but only seven randomly selected
O3:K6, one O3:KUT and one O1:K20 isolates are shown in the
Figure 3. Our REP-PCR studies revealed 11 discernible prod-
ucts (i.e., PCR bands) ranging in size from 400 to 3,000 bp.
Several REP-PCR products with molecular size of 600, 750,
and 1500 bp were common to most strains, while products
of 400, 800, 1000, and 3000 bp were present in all V. para-
haemolyticus strains (Figure 3). One REP-PCR banding pattern
was obtained for O3:K6 (tdh+, toxRS/new+ , orf8+, and trh−)
strains; these seven isolates (Figure 3, lanes 1–5, 7, 9), yielded
an identical banding pattern to that observed for the control
strains (Figure 3, lane 10). A second banding pattern com-
prised one isolate, O3:KUT (tdh+ , toxRS/new+, orf8+ and trh−),
(Figure 3, lane 6) and a third REP-PCR banding pattern was
obtained with one isolate, O1:K20 (tdh− , toxRS/new− , orf8−,
and trh−; Figure 3, lane 8). Similar REP-PCR banding pattern
were observed when REP-PCR was repeatedly performed, at
least three times, demonstrating the reproducibility of our data.
Except for the O3:KUT, lane 6 and O1:K20, lane 8 which dis-
played non-identical REP-PCR proﬁles, isolates from any year
with the same serotype mostly produced identical REP-PCR
proﬁles.
Antibiotic Resistance Profiles of
V. parahaemolyticus Strains
Of the environmental and clinical strains tested, a signiﬁcant
increase in cefotaxime resistance was observed from 2004–2010
to 2011–2013 (p< 0.05) and most isolates were resistant to ampi-
cillin (Table 2). However, among clinical strains a signiﬁcantly
ampicillin-resistance decreased was observed from 2004–2010
to 2011–2013 (p < 0.05). Low resistance was determined for
gentamicin, nalidixic acid, sulfamethoxazole-trimethoprim, cef-
tazidime, chloramphenicol, and tetracycline from 2004–2010 to
2011–2013 (Table 2). Clinical and environmental isolates were all
susceptible to ciproﬂoxacin or chloramphenicol, respectively.
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TABLE 1 | Serovar and virulence attributes of 295 Vibrio parahaemolyticus strains isolated between 2011 and 2013.
O serogroup and serovar Total no.
of isolates
Presence of each virulence gene No. of clinical
isolates (from feces)
No. of environmental
isolated from:
tdh trh toxRS/new Orf8 Sh Sw S
O1
O1:KUT 2 + −- − − 1 1
1 − − − − 1
1 + + − − 1
O1:K20 1 − − − − 1
O1:K56 1 + + − − 1
O2
O2:KUT 2 + − − − 2
1 − − − − 1
O3
O3:KUT 2 − − − − 1 1
6 + − − + 5 1
2 + − − − 1 1
1 + − + − 1
1 + − + + 1
1 + + − − 1
O3:K6 192 + − + + 191 1
5 + − + − 5
21 + − − + 21
4 + + + + 4
O3:K29 1 + − + − 1
O3:K30 1 − − − − 1
O3:K33 1 + − − + 1
2 − − − − 2
O3:K54 1 − − − − 1
O4
O4:KUT 2 + + − − 2
O4:K4 1 + − − − 1
O4:K12 1 + − − − 1
O4:K29 1 + − − − 1
O4:K55 1 + − − − 1
O4:K63 1 − − − − 1
O5
O5:K30 2 − − − − 2
1 + − − + 1
2 + − − − 2
O6
O6:K18 1 + + − − 1
1 + − − − 1
O6:K46 2 − − − − 1 1
O8
O8:K21 1 + + − − 1
O10
O10:KUT 2 + − − − 2
O11
O11:KUT 1 − − − − 1
OUT
OUT:KUT 14 + − − − 2 11 1
1 − + − − 1
1 + − + + 1
1 + − − + 1
(Continued)
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TABLE 1 | Continued
O serogroup and serovar Total no.
of isolates
Presence of each virulence gene No. of clinical
isolates (from feces)
No. of environmental
isolated from:
tdh trh toxRS/new Orf8 Sh Sw S
1 + + − − 1
5 − − − − 3 1 1
OUT:K6 1 + − − − 1
OUT:K53 1 + − − − 1
38 3 5
TOTAL
295
Total clinical:
249
Total environmental: 46
Sh, Shrimp; Sw, Seawater; S, Sediment.
FIGURE 3 | Agarose gel (1.5%) electrophoresis showing the results of
polymerase chain reaction (PCR) amplification of representative
fingerprint patterns for the REP-PCR of Vibrio parahaemolyticus
strains of serotype O3:K6 (tdh+, toxRS/new+, orf8+, and trh−),
isolated from 2004 to 2013. Lane M, 1 kb molecular size markers; lane 1,
clinical isolate (2004, O3:K6); lane 2, clinical isolate (2006, O3:K6); lane 3,
clinical isolate (2008, O3:K6); lane 4, clinical isolate (2010, O3:K6); lane 5,
clinical isolate (2011, O3:K6); lane 6, shrimp isolate (2011, O3:KUT, tdh+ ,
toxRS/new+ , orf8+ , and trh− ); lane 7, clinical isolate (2012, O3:K6); lane 8,
clinical isolate (2012, O1:K20, tdh− , toxRS/new− , orf8− , and trh− ); lane 9,
clinical isolate (2013, O3:K6); lane 10, control strain V. parahaemolyticus
RIMD 2210633 (tdh+ , toxRS/new+ , orf8+ , and trh− ); lane 11, negative
control (no DNA template added to the rep-PCR reaction); lane 12,
molecular size markers.
Regarding overall antibiotic resistance, most environmental
(>78%) and clinical strains (>70%) were non-susceptible to at
least one antibiotic (Table 3). This high prevalence of resis-
tance decreased in strains isolated in 2011–2013 in compari-
son to previous period, 2004–2010, with an expected increase
on the prevalence of strains resistant to two or more antibi-
otics (multidrug-resistant; Table 3). The increased prevalence,
however, of strains with resistance to two antibiotics was
only statistically signiﬁcant among clinical isolates (p < 0.05).
Importantly, strains with resistance to 5 or 7 antibiotics were
detected among clinical strains isolated in the period 2011–2013
(Table 3).
Discussion
In Mexico, the ﬁrst outbreak of gastroenteritis caused by pan-
demic V. parahaemolyticus strain O3:K6 was reported in a
relatively small geographical area of the Southern part of the
Sinaloa State (Velazquez-Roman et al., 2012). Since its arrival
back in 2004, Sinaloa has experienced recurrent sporadic cases
of gastroenteritis caused by V. parahaemolyticus strains which
have gradually spread from south to north from 2004 to 2010
(Velazquez-Roman et al., 2012). The present study conducted
an epidemiological surveillance of V. parahaemolyticus strains in
both environmental and clinical samples along the Paciﬁc coast
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TABLE 2 | Distribution of antibiotic resistance among clinical and environmental Vibrio parahaemolyticus strains isolated from 2004–2010 and 2011–2013
periods.
Antimicrobial agents Sample type
Environmental Clinical
2004–2010 n = 87 (%) 2011–2013 n = 32 (%) 2004–2010 n = 65 (%) 2011–2013 n = 77 (%)
Aminoglycoside
Gentamicin 2 (2.3%) 1 (3.1%) 0 3 (3.9%)
Quinolones and fluoroquinolones
Ciprofloxacin 1 (1.1%) 0 0 0
Nalidixic acid 1 (1.1%) 0 1 (1.5%) 4 (5.2%)
Sulfonamides and potentiated sulfonamides
Sulfamethoxazole-trimethoprim 2 (2.3%) 0 0 2 (2.6%)
Tetracyclines
Tetracycline 1 (1.1%) 0 1 (1.5%) 1 (1.3%)
Beta lactams
Ampicillin 78 (89.7%) 32 (100%) 65 (100%)∗ 70 (90.1%)∗
Cephalosporins
Ceftazidime 3 (3.4%) 0 0 4 (5.2%)
Cefotaxime 3 (3.4%)∗ 7 (21.9%)∗ 4 (6.1%)∗ 14 (18.2%)∗
Phenicols
Chloramphenicol 0 0 0 3 (3.9%)
∗Significant at 0.05 level.
TABLE 3 | Drug resistance and multidrug-resistance among clinical and environmental Vibrio parahaemolyticus strains isolated from 2004–2010 and
2011–2013 periods.
Number of drugs resistant to: Sample type
Environmental Clinical
2004–2010 n = 87 (%) 2011–2013 n = 32 (%) 2004–2010 n = 65 (%) 2011–2013 n = 77 (%)
0 7 (8.1%) 0 0 5 (6.5%)*
1 72 (82.8%) 25 (78.1%) 60 (92.3%)* 54 (70.1%)*
2 6 (6.9%) 6 (18.8%) 4 (6.2%)* 13 (16.9%)*
3 1 (1.1%) 1 (3.1%) 1 (1.5%) 3 (3.9%)
4 1 (1.1%) 0 0 0
5 0 0 0 1 (1.3%)
6 0 0 0 0
7 0 0 0 1 (1.3%)
≥8 0 0 0 0
∗Significant at 0.05 level.
of Sinaloa from 2011 to 2013. We demonstrate that the pandemic
clone O3:K6 (encoding the tdh and toxRS/new genes and with or
without orf8) still remains the most prevalent serotype isolated
from cases of V. parahaemolyticus-induced diarrhea cases. The
pandemic clone has endemically established in the Paciﬁc Coast
of Mexico. Furthermore, most strains were resistant to ampi-
cillin and resistance to multiple ﬁrst-line antibiotics signiﬁcantly
increased from 2004–2010 to 2011–2013. These observations
represent, to the best of our knowledge, the ﬁrst report demon-
strating 10 years of persistence of the pandemic clone O3:K6 in
the Mexico’s paciﬁc coast.
As in our previous study where most strains isolated from
2004 to 2010 belonged to the O3:K6 serotypes, most strains
isolated from 2011 to 2013 were serotype O3:K6 (Velazquez-
Roman et al., 2012). The prevalence of O3:K6 pandemic and
pathogenic strains isolated from environmental and clinical sam-
ples was not signiﬁcantly diﬀerent from that detected in 2004–
2010. This indicates that (1) the incidence of V. parahaemolyticus
infection by the pandemic strains remains similar and (2) that
the pandemic clone is a permanent resident of the environment
in this region of Mexico. We hypothesize that the presence of
pandemic strains in the environment is at least partially due to
shedding in the feces of patients with gastroenteritis.
Regional persistence of O3:K6 pandemic strains have been
reported in diﬀerent geographic areas. For example, O3:K6 was
the predominant serovar in studies conducted in Peru in 2007
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(Gil et al., 2007), China (2007–2012; Li et al., 2014), and other
Asian countries (Arakawa et al., 1999; Chowdhury et al., 2000;
Wong et al., 2000) as well as in Chile when investigated from
2004 to 2009 (Gonzalez-Escalona et al., 2005; Cabello et al., 2007;
Fuenzalida et al., 2007; Garcia et al., 2009). A follow up study
in Chile conducted in by Harth et al. (2009) made an interest-
ing observation of serotype replacement. The authors reported a
decrease in outbreaks caused by O3:K6 but an increase of cases
caused by pandemic isolates belonging to serotype O3:K59. In
contrast, no change in the prevalence of the O3:K6 pandemic
clone was observed in Northwest Mexico from 2004 to 2013. Our
studies also identiﬁed new serovariants (O3:K29 and OUT:KUT)
emerging with virulence attributes (tdh positive, toxRS/new posi-
tive and/or orf8 positive) of pandemic strains. The emergence of
new serovariants warrants further investigation since clones can
potentially produce outbreaks along the northern Mexican coast-
line of the Paciﬁc Ocean and spread to South Mexico or head
North to US and Canada.
Results showed that the serovars of V. parahaemolyticus in
environmental and clinical isolates were abundant and variable.
We identiﬁed 10 novel serovars (from 2011 to 2013) in the
area that were not isolated in our previous investigation con-
ducted during 2004–2010. These newly identiﬁed serovars were
isolated from diarrhea cases, N = 7, (O1:K20, O3:K30, O3:K54,
O4:K29, O4:K55, O6:K18, and OUT:K53) and three from envi-
ronmental samples (O4:K4, O5:K30, and OUT:K6). Data from
the present study are in accordance with other reports in which
V. parahaemolyticus environmental strains show a high serolog-
ical variability (Nair et al., 2007; Chao et al., 2009; Garcia et al.,
2009).
Previous studies have demonstrated that up to 90% of clini-
cal strains encode the tdh and/or trh gene (Okuda et al., 1997;
Chao et al., 2009; Garcia et al., 2009; Velazquez-Roman et al.,
2012; Li et al., 2014; Pazhani et al., 2014), whereas their presence
in environmental isolates is rare (Shirai et al., 1990; DePaola
et al., 2000; Yeung and Boor, 2004; Nair et al., 2007; Chao et al.,
2009; Velazquez-Roman et al., 2012). More recently, however,
an increased proportions (48–52%) of strains encoding virulence
genes (i.e., tdh and/or trh) have been detected in environmen-
tal isolates obtained in Mexico and the US. (Paranjpye et al.,
2012; Velazquez-Roman et al., 2012; Gutierrez West et al., 2013).
Accordingly, our studies detected high prevalence of the tdh gene
(encoding for the TDH hemolysin) as it was carried by 58.6% of
all environmental strains isolated from 2004 to 2013. Besides this
demonstrated high serodiversity in the environment of V. para-
haemolyticus strains with pathogenic potential (i.e., non-O3:K6
strains encoding the tdh gene), the pandemic strain O3:K6 caused
>81% of reported cases of gastroenteritis, attributable to V. para-
haemolyticus between 2004 and 2013 in the Paciﬁc Northwest
coast of Mexico. The detection of tdh gene in environmental
isolates suggests that tdh alone is not an adequate marker for
potentially virulent V. parahaemolyticus strains (Paranjpye et al.,
2012).
As expected, our studies found a high serodiversity of V.
parahaemolyticus in the environment, including isolates obtained
from shrimp, sediment, and seawater. It is worth to mention
that in 2013 we observed a high mortality of cultured Penaeus
vannamei in shrimp farms located in northern Mexico includ-
ing the states of Nayarit, Sinaloa and Sonora. Mortality was due
to acute hepatopancreatic necrosis disease (AHPND), which has
also been referred to as early mortality syndrome (EMS), and the
pathogen associated with EMS was V. parahaemolyticus (Gomez-
Gil et al., 2014; Gomez-Jimenez et al., 2014; Nunan et al., 2014).
Additional studies should provide a link between pathogenic
traits of V. parahaemolyticus strains and/or serotype or serovars,
if any, associated to this syndrome in shrimps.
Rep-PCR genomic ﬁngerprinting is known to have a greater
resolving power than serotyping (Maluping et al., 2005). Our
rep-PCR studies intended to demonstrate genetic similarities, or
diﬀerences, between pandemic strains isolated from the environ-
ment with those isolated from human cases of gastroenteritis.
Whereas molecular divergence was noticed on the banding pro-
ﬁle obtained from O1:K20 and O3:KUT strains, we obtained a
similar rep-PCR proﬁle in all O3:K6 pandemic isolates utilized
which indicates that O3:K6 strains circulating in the environ-
ment have the same clonal origin than those infected patients and
therefore a source of infection and transmission.
Another important contribution in our work was the investi-
gation of susceptibility, or not, of the isolatedV. parahaemolyticus
strains to ﬁrst-line antibiotics utilized in the region. In agree with
our genetic evidences (i.e., rep-PCR) indicating genetic relation-
ships of the isolated strains, our results revealed similar resistance
patterns in both clinical and environmental isolates. Most V.
parahaemolyticus isolates were resistant to ampicillin which was
not a surprise as non-susceptibility to ampicillin is very common
in V. parahaemolyticus strains isolated from enviromental and
clinical samples (Okuda et al., 1997; Wong et al., 2000; Roque
et al., 2001; Sun et al., 2013), suggesting that these drugs have a
negligible role in the treatment of V. parahaemolyticus. In con-
trast, most isolates were sensitive to tetracycline, trimethoprim–
sulfamethoxazole, chloramphenicol, nalidixic acid, ciproﬂoxacin,
ceftazidime and gentamicin, which can be used as an alternative
antibiotic therapy. Resistance to cefotaxime increased from 4.6%
in 2004–2010 to 19.3% in 2011–2013. A similar prevalence of
resistance to cefotaxime (20%) has also been reported in strains
isolated in Italy from shellﬁsh and clinical samples (Ottaviani
et al., 2013).While the percentage of isolates expressing resistance
to the newer generation of cephalosporins was relatively low,
these antibiotics are considered to be some of the best defenses
against the severe infections that these organisms can elicit, so
even a small percentage of resistant isolates could be cause for
concern. Therefore, all isolates must be tested for antimicrobial
susceptibility to monitor resistance patterns of each antibiotic. In
Mexico and others countries, patients suﬀering V. parahaemolyti-
cus disease are treated with empiric antibiotic therapy which
generates more resistance to ﬁrst line antibiotics. Unlike other
bacterial infections, little to nothing is reported about antibiotic
resistance of V. parahaemolyticus in Mexico, and perhaps other
Latin American countries, as clinical laboratories do not routinely
test susceptibility to diﬀerent classes of antimicrobial agents.
Furthermore, until 2004 where we reported the ﬁrst outbreak of
gastroenteritis caused by V. parahaemolyticus in Mexico, there
had not been other outbreaks published in the scientiﬁc literature
(Velazquez-Roman et al., 2012, 2014). Prior to our studies, only
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few environmental strains had been isolated from water and ﬁsh
in Mexico (Cabrera-Garcia et al., 2004).
To the best of our knowledge, our ﬁndings represent the ﬁrst
investigation in Mexico about the prevalence, pathogenic poten-
tial, and antimicrobial susceptibility over a 10-years period of
continue surveillance of V. parahaemolyticus (pathogenic and
pandemic O3:K6 clone) in both clinical specimens and envi-
ronmental samples. Most gastroenteritis cases attributable to V.
parahaemolyticus strains are caused by the same pandemic clone
which warrants extended surveillance in the region and across the
country. Continued monitoring of V. parahaemolyticus strains
and their susceptibility to antibiotics seem to be necessary to
unsure the best treatment, and prognosis, to patients with V.
parahaemolyticus diseases in the area. This information should
also be relevant to health authorities in the case of a local or mul-
tistate foodborne outbreak ofV. parahaemolyticus gastroenteritis.
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